AGIO icon

Agios Pharmaceuticals
AGIO

Overview Fund Activity

198 hedge funds and large institutions have $4.49B invested in Agios Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 83 increasing their positions, 47 reducing their positions, and 20 closing their positions.

Holders
198
Holders Change
+20
Holders Change %
+11.24%
% of All Funds
4.54%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.11%
New
42
Increased
83
Reduced
47
Closed
20
Calls
$24M
Puts
$25.2M
Net Calls
-$1.2M
Net Calls Change
+$3.76M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$256M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$703M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$636M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$327M
5
PHS
5
PFM Health Sciences
California
$55.4M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$2.05M
2
Balyasny Asset Management
2
Balyasny Asset Management
Illinois
$55.9M
3
Capital World Investors
3
Capital World Investors
California
$34.3M
4
BB
4
BB Biotech
Switzerland
$207M
5
PI
5
Putnam Investments
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$703M 8,599,011 +1,289,268 +18%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$636M 7,772,274 +946,674 +14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$327M 4,000,421 +698,325 +21%
BlackRock
4
BlackRock
New York
$262M 3,206,053 +393,336 +14%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$256M 3,126,023 +1,301,177 +71%
Capital International Investors
6
Capital International Investors
California
$231M 2,822,284 +9,182 +0.3%
BB
7
BB Biotech
Switzerland
$207M 2,535,253 -184,745 -7%
ClearBridge Investments
8
ClearBridge Investments
New York
$125M 1,528,408 +10 +0%
State Street
9
State Street
Massachusetts
$122M 1,489,508 +146,869 +11%
Goldman Sachs
10
Goldman Sachs
New York
$94.2M 1,151,304 +104,747 +10%
Lord, Abbett & Co
11
Lord, Abbett & Co
New Jersey
$85.4M 1,044,346 +665,684 +176%
Invesco
12
Invesco
Georgia
$68.6M 838,654 -9,240 -1%
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$55.9M 683,364 -446,899 -40%
PHS
14
PFM Health Sciences
California
$55.4M 677,091 +677,091 New
First Trust Advisors
15
First Trust Advisors
Illinois
$55.3M 675,756 -137,891 -17%
Alkeon Capital Management
16
Alkeon Capital Management
New York
$54.7M 668,789 +157,170 +31%
CGT
17
Capital Guardian Trust
California
$54.1M 661,262 -1,827 -0.3%
Deutsche Bank
18
Deutsche Bank
Germany
$49.8M 608,952 +438,490 +257%
Baillie Gifford & Co
19
Baillie Gifford & Co
United Kingdom
$47.6M 582,141 +582,141 New
ACH
20
ArrowMark Colorado Holdings
Colorado
$46.8M 571,914 +433,546 +313%
AG
21
Artal Group
Luxembourg
$40.9M 500,000 – –
Ameriprise
22
Ameriprise
Minnesota
$40.8M 498,421 +443,934 +815%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$34.6M 423,601 +54,089 +15%
Capital World Investors
24
Capital World Investors
California
$34.3M 420,000 -243,000 -37%
Point72 Asset Management
25
Point72 Asset Management
Connecticut
$33.2M 406,090 +314,590 +344%
1
2 3 4 5